CARGO Therapeutics Inc. C...
(CRGX)
undefined
undefined%
At close: undefined
Company Description
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.
The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies.
It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets.
The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022.
CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.
CARGO Therapeutics Inc. Common Stock
| Country | United States |
| IPO Date | Nov 13, 2023 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 170 |
| CEO | Gina Chapman |
Contact Details
Address: 1900 Alameda De Las Pulgas San Mateo, United States | |
| Website | https://cargo-tx.com |
Stock Details
| Ticker Symbol | CRGX |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001966494 |
| CUSIP Number | 14179K101 |
| ISIN Number | US14179K1016 |
| Employer ID | 84-4080422 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Gina Chapman | President, Chief Executive Officer & Director |
| Anup Radhakrishnan | Chief Financial Officer, Secretary & Chief Operating Officer |
| Dr. Crystal L. Mackall M.D. | Co-Founder & Scientific Advisory Board Chair |
| Dr. Ginna G. Laport M.D. | Chief Medical Officer |
| Dr. Louai Labanieh | Founder |
| Dr. Michael Ports Ph.D. | Chief Scientific Officer |
| Dr. Robbie Majzner M.D. | Co-Founder & Scientific Advisory Board Member |
| Dr. Shishir Gadam Ph.D. | Chief Technical Officer |
| Faisal Shawwa M.B.A. | Senior Vice President of Finance & Accounting |
| Nancy Goodman J.D. | Founder |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 06, 2024 | S-3ASR | Automatic shelf registration statement of securiti... |
| Nov 15, 2024 | 4 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 13, 2024 | 424B3 | Filing |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 08, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |